Construction of γ-synuclein eukaryotic expression vector and its effect on invasion and metastasis of colon cancer cell line SW1116 in vitro.
- Author:
Qing YE
1
;
Feng HUANG
;
Qiuhong ZHENG
;
Xiaoying WANG
;
Yangmei XU
;
Fusheng GONG
;
Lijie HUANG
Author Information
- Publication Type:Journal Article
- MeSH: Cell Adhesion; Cell Line, Tumor; Colonic Neoplasms; pathology; Genetic Vectors; biosynthesis; Human Umbilical Vein Endothelial Cells; Humans; Neoplasm Invasiveness; Neoplasm Metastasis; gamma-Synuclein; genetics
- From: Chinese Journal of Gastrointestinal Surgery 2014;17(1):36-40
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo construct γ-synuclein gene eukaryotic expression vector, and to study its effect on the invasion of colon cancer cell line SW1116 and the adhesion between SW1116 and human umbilical vein endothelial cells(HUVECs) in vitro.
METHODSTotal RNA was extracted from colon cancer cell line HT29 and the cDNA of γ-synuclein was amplified using RT-PCR. The digested fragment of cDNA coding sequence was linked to the eukaryotic expression vector pEGFP-C1 containing the GFP gene. After identification by sequence analysis, the recombinant plasmid was transfected into colon cancer cell line SW1116 via lipofectamine. The stable cell line was selected with G-418. The invasion in vitro was tested by Transwell invasion chamber assay. HUVECs were previously seeded onto 96-well plates before SW1116 cells seeded, and fluorescence intensity of GFP was detected to represent the amount of adhesion cells by ELISA.
RESULTSHuman γ-synuclein eukaryotic expression vector was successfully constructed, which was stably expressed in SW1116 cells and could translate the GFP-γ-synuclein protein in vitro. γ-synuclein facilitated SW1116 cell passing through matrigel and filter membrane(198.4±20.7 vs. 98.8±13.2, P<0.05) and elevated the adherence of SW1116 cells to HUVECs(3.08±0.36 vs. 1.22±0.21, P<0.05).
CONCLUSIONExpression of γ-synuclein can strengthen colon cancer cell SW1116 potentiality of invasion and metastasis in vitro.